Virulence factors of Cryptococcus neoformans (Q40927145)

24 September 2017

1 reference

title

Virulence factors of Cryptococcus neoformans (English)

1 reference

24 September 2017

main subject

Cryptococcus neoformans

1 reference

1

Kozel TR

1 reference

30 October 2018

publication date

1 August 1995

1 reference

24 September 2017

published in

Trends in Microbiology

1 reference

24 September 2017

volume

3

1 reference

24 September 2017

issue

8

1 reference

24 September 2017

page(s)

295-299

1 reference

Epidemiologic differences between the two varieties of Cryptococcus neoformans

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Ecology, life cycle, and infectious propagule of Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Cryptococcus neoformans. I. Nonencapsulated mutants.

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Decreased virulence in stable, acapsular mutants of cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Cryptococcus neoformans. 3. Inhibition of phagocytosis.

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Effect of mannose-binding protein on binding of Cryptococcus neoformans to human phagocytes.

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Enhancement of HIV type 1 infectivity in vitro by capsular polysaccharide of Cryptococcus neoformans and Haemophilus influenzae.

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Antioxidant function of fungal melanin

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Decreased susceptibility of melanized Cryptococcus neoformans to UV light

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B.

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Regulation of mannitol biosynthesis and degradation by Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Distribution of alpha and alpha mating types of Cryptococcus neoformans among natural and clinical isolates

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Genetic association of mating types and virulence in Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. II. Biological activity of the enzyme

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(00)88957-X

7 January 2021

10.1016/S0966-842X(00)88957-X

Identifiers

DOI

1 reference

24 September 2017

1 reference